Jevtana Related Clinical Trials
Dose-Escalation, Safety, Pharmacokinetics Study of Cabazitaxel With Gemcitabine In Patients With Solid Tumor [Recruiting]
Cabazitaxel - PF Induction Chemotherapy [Recruiting]
Phase II Study of Cabazitaxel-XRP6258 in Advanced Non-Small Cell Lung Cancer [Recruiting]
Cabazitaxel With Radiation and Hormone Therapy for Prostate Cancer [Recruiting]
Cabazitaxel in Men 75 Years of Age or Older With Castration-Resistant Prostate Cancer [Not yet recruiting]
Cabazitaxel With or Without Carboplatin in Patients With Metastatic Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Therapy [Recruiting]
Phase I/II Cabazitaxel for Recurrent Malignant Glioma [Not yet recruiting]
Ph Ib/IIa Study of Cabazitaxel Plus Bavituximab in Castration-resistant Prostate Cancer [Recruiting]
Study of Weekly Cabazitaxel for Advanced Prostate Cancer [Not yet recruiting]
A Study to Evaluate the Effects of Combining Cabazitaxel With Cisplatin Given Every 3 Weeks in Patients With Advanced Solid Cancer [Recruiting]
Cabazitaxel in Pediatric Patients With Refractory Solid Tumors Including Central Nervous System Tumors [Recruiting]
Chemotherapy for Patients With Gastroesophageal Cancers Who Have Progressed After One Prior Chemo Regimen [Recruiting]
Cabazitaxel in Patients With Urothelial Carcinoma Who Have Disease Progression Following Platinum-Based Chemotherapy [Recruiting]
Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment [Recruiting]
Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen [Recruiting]
A Study Looking at Novel Scheduling of Cabazitaxel for Patients With Metastatic Prostate Cancer [Not yet recruiting]
Cabazitaxel Plus Prednisone With Octreotide For Castration-Resistant Prostate Cancer (CRPC) Previously Treated With Docetaxel [Recruiting]
Comparison of Cabazitaxel/Prednisone Alone or in Combination With Custirsen for 2nd Line Chemotherapy in Prostate Cancer [Recruiting]
Cabazitaxel and Abiraterone Acetate in Patients With Metastatic Castrate-Resistant Prostate Cancer [Recruiting]
Phase II Study of Cabazitaxel in Refractory Metastatic Gastric or Gastroesophageal Adenocarcinoma [Not yet recruiting]
Pharmacokinetics and Safety Study of Cabazitaxel in Cancer Patients With Renal Impairment [Recruiting]
Cabazitaxel in Asian Patients With Advanced Gastric Cancer Who Failed Prior Chemotherapy [Recruiting]
Cabazitaxel at 20 mg/m² Compared to 25 mg/m² With Prednisone for the Treatment of Metastatic Castration Resistant Prostate Cancer [Recruiting]
Cabazitaxel Versus Docetaxel Both With Prednisone in Patients With Metastatic Castration Resistant Prostate Cancer [Recruiting]
Effect of Cabazitaxel on the QTc Interval in Cancer Patients [Recruiting]
Dose Escalation Study With Cabazitaxel in Combination With Daily Prednisolone in Patients With Hormone Refractory Prostate Cancer [Recruiting]
A Study Evaluating the Pain Palliation Benefit of Adding Custirsen to Docetaxel Retreatment or Cabazitaxel as Second Line Therapy in Men With Metastatic Castrate Resistant Prostate Cancer (mCRPC) [Recruiting]
GEMOX in Docetaxel-Refractory Castration-Resistant Prostate Cancer [Recruiting]
|
